Publication: Epac is required for exogenous and endogenous stimulation of adenosine A<inf>2B</inf> receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation
Issued Date
2018-06-01
Resource Type
ISSN
15739546
15739538
15739538
Other identifier(s)
2-s2.0-85040333944
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Purinergic Signalling. Vol.14, No.2 (2018), 141-156
Suggested Citation
Sarawuth Phosri, Kwanchai Bunrukchai, Warisara Parichatikanond, Vilasinee H. Sato, Supachoke Mangmool Epac is required for exogenous and endogenous stimulation of adenosine A<inf>2B</inf> receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation. Purinergic Signalling. Vol.14, No.2 (2018), 141-156. doi:10.1007/s11302-017-9600-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/45137
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Epac is required for exogenous and endogenous stimulation of adenosine A<inf>2B</inf> receptor for inhibition of angiotensin II-induced collagen synthesis and myofibroblast differentiation
Other Contributor(s)
Abstract
© 2018, Springer Science+Business Media B.V., part of Springer Nature. Angiotensin II (Ang II) plays an important role on the pathogenesis of cardiac fibrosis. Prolong and overstimulation of angiotensin II type 1 receptor with Ang II-induced collagen synthesis and myofibroblast differentiation in cardiac fibroblasts, leading to cardiac fibrosis. Although adenosine and its analogues are known to have cardioprotective effects, the mechanistic by which adenosine A2 receptors (A2Rs) inhibit Ang II-induced cardiac fibrosis is not clearly understood. In the present study, we examined the effects of exogenous adenosine and endogenous adenosine on Ang II-induced collagen and myofibroblast differentiation determined by α-smooth muscle action (α-SMA) overexpression and their underlying signal transduction. Elevation of endogenous adenosine levels resulted in the inhibition of Ang II-induced collagen type I and III and α-SMA synthesis in cardiac fibroblasts. Moreover, treatment with exogenous adenosine which selectively stimulated A2Rs also suppressed Ang II-induced collagen synthesis and α-SMA production. These antifibrotic effects of both endogenous and exogenous adenosines are mediated through the A2B receptor (A2BR) subtype. Stimulation of A2BR exhibited antifibrotic effects via the cAMP-dependent and Epac-dependent pathways. Our results provide new mechanistic insights regarding the role for cAMP and Epac on A2BR-mediated antifibrotic effects. Thus, A2BR is one of the potential therapeutic targets against cardiac fibrosis.